These results suggest that DEPDC1, a glycolysis-related gene could serve as a prognostic marker for poor prognosis and aggressive disease progression in KIRC patients, potentially influencing drug resistance and enhancing glycolysis in RCC. The gene discussed is DEPDC1; the disease is renal cell carcinoma.